(15 days)
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Fetal - OB/GYN, Abdominal, Intra-operative (Abdominal organs and vascular), Laparoscopic, Pediatric, Small Organ (breast, thyroid, testicles.), Neonatal Cephalic, Adult Cephalic, Trans-rectal, Trans-vaginal, Trans-urethral, Musculo-skel. (Conventional), Musculo-skel. (Superficial), Cardiac Adult, Cardiac Pediatric, Peripheral vessel.
Typical examinations performed using the SonoSite hand-carried ultrasound system (C2 Series) are: Abdominal Imaging Applications, Cardiac Imaging Applications, Cephalic Imaging Applications, Gynecology and Infertility Imaging Applications, Interventional and Intraoperative Imaging Applications, Obstetrical Imaging Applications, Pediatric and Neonatal Imaging Applications, Prostate Imaging Applications, Superficial Imaging Applications, Vascular Imaging Applications.
The SonoSite hand-carried ultrasound system, C2 Series is a highly portable, software controlled ultrasound system used to acquire and display highresolution, real-time ultrasound data in 2D, Pulsed Wave (PW) Doppler, Continuous Wave (CW) Doppler, Color Power Doppler, Velocity Color Doppler (VCD) and Directional Color Power Doppler, or in a combination of these modes.
The System has an electrocardiography (ECG) display feature and supports a 3lead ECG cable assembly to collect data for M-mode measurements. The System provides measurement capabilities for anatomical structures and fetal biometry that provide information used for clinical diagnostic purposes. The System has a PW and CW Doppler audio output feature and cine review, image zoom, labeling, biopsy, measurements and calculations, image storage and review, printing, and recording capabilities. The system includes Digital Imaging and Communications (DICOM) to capabilities to provide the acceptance, transfer, display, storage, and digital processing of ultrasound images.
The SonoSite hand-carried ultrasound system (C2 Series) is designed to accept curved or linear transducers of the types and frequency listed in the table below. All actions affecting the performance of the transducer are activated from the main system control panel.
The provided text is a 510(k) Summary of Safety and Effectiveness for the SonoSite hand-carried ultrasound system (C2 Series). This document focuses on demonstrating substantial equivalence to predicate devices and detailing the intended use and technological characteristics. Crucially, it does not include information about clinical studies, acceptance criteria, or performance metrics in the way a clinical validation study would.
Therefore, I cannot extract the information required to populate a table of acceptance criteria and reported device performance or describe a study proving the device meets acceptance criteria as envisioned by your request. The document describes the device's technical specifications and intended uses, and lists applicable standards, but not specific performance metrics against acceptance criteria from a clinical study.
Here's a breakdown of what can be extracted based on the provided text, and what cannot:
What can be extracted:
- Device Description: The SonoSite hand-carried ultrasound system, C2 Series, is a highly portable, software-controlled ultrasound system for acquiring and displaying high-resolution, real-time ultrasound data in various modes (2D, PW Doppler, CW Doppler, Color Power Doppler, Velocity Color Doppler (VCD), Directional Color Power Doppler). It includes ECG display, measurement capabilities, audio output, cine review, image zoom, labeling, biopsy, storage, printing, recording, and DICOM capabilities.
- Intended Use: The system is intended for numerous clinical applications, including Fetal-OB/GYN, Abdominal, Intra-operative, Laparoscopic, Pediatric, Small Organ, Neonatal Cephalic, Adult Cephalic, Trans-rectal, Trans-vaginal, Trans-urethral, Musculoskeletal (Conventional and Superficial), Cardiac Adult, Cardiac Pediatric, and Peripheral Vessel. Specific modes of operation are cleared for each application (B-mode, M-mode, PWD, CWD, Color Doppler, Combined modes, and other specialized modes like Color Power Doppler, Directional Color Power Doppler, 3-D Imaging, and Tissue Harmonic Imaging).
- Technological Characteristics:
- Operates identically to predicate devices, using piezoelectric material in the transducer to transmit and receive sound waves, converting them to electrical signals for display.
- Conforms to AIUM/NEMA standards for on-screen display of thermal and mechanical acoustic output indices (ALARA principle).
- Acoustic output limits:
- ISPTA(d): 720 mW/cm² (Maximum)
- TIS/TIB/TIC: 0.1 - 4.0 (Range)
- Mechanical Index (MI): 1.9 (Maximum)
- ISPPA(d): 0 - 700 W/cm² (Range)
- Transducers: The submission lists multiple transducers (C11/7-4, C11e/10-5, C15/4-2, C60/5-2, HST/10-5, ICT/7-4, C8/8-5, ICTe/10-5, L25/10-5, L38/10-5, L52/10-5, L52S/10-5, and a 2.0 MHz Dual Element Circular Array) with their frequency ranges and cleared indications for use.
- Regulatory Nature: This is a 510(k) premarket notification, indicating a claim of substantial equivalence to legally marketed predicate devices, not a de novo clearance or PMA requiring extensive de novo clinical studies with predefined acceptance criteria for performance endpoints.
What cannot be extracted (and why):
- A table of acceptance criteria and the reported device performance: This document explicitly states it is a "Summary Of Safety And Effectiveness" and repeatedly references "substantial equivalence" to predicate devices (K014116, K010374, and Philips Ultrasound HDI® 5000 Ultrasound System). Substantial equivalence primarily relies on demonstrating that the new device has the same intended use and similar technological characteristics as predicate devices, or that differences do not raise new questions of safety or effectiveness. It does not typically involve establishing new, quantitative acceptance criteria for performance (e.g., sensitivity, specificity, accuracy) based on clinical data and then proving the device meets those criteria with a new study. The performance is deemed acceptable because it is similar to already cleared devices.
- Sample size used for the test set and the data provenance: No new clinical test sets or studies are described in this document for the purpose of establishing performance against acceptance criteria. The clearance is based on comparison to existing, already cleared devices.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts: As no new clinical study measuring performance against ground truth is presented, this information is not available.
- Adjudication method for the test set: Not applicable, as no new test set is described.
- If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This device is a diagnostic ultrasound system, not an AI-assisted diagnostic tool in the sense of a software-only device. There is no mention of such a study.
- If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. This is a hardware/software system, not a standalone algorithm.
- The type of ground truth used (expert consensus, pathology, outcomes data, etc): Not applicable, as no new clinical study is detailed.
- The sample size for the training set: Not applicable.
- How the ground truth for the training set was established: Not applicable.
In summary, the provided 510(k) submission is a regulatory document focused on demonstrating equivalence to existing devices through descriptions of technological characteristics and intended uses, rather than a report on a clinical study with predefined acceptance criteria and performance results.
{0}------------------------------------------------
510(K) Summary Of Safety And Effectiveness
This summary of safety and effectiveness is provided as part of this Premarket Notification in compliance with 21 CFR, Part 807, Subpart E, Section 807.92.
- Submitter's name, address, telephone number, contact person: 1)
SonoSite, Inc. 21919 30th Drive SE Bothell, WA 98021-3904
| Corresponding Official: | Michael A. Hoffman |
|---|---|
| Director – Quality Assurance and Regulatory Affairs | |
| E-mail: | michael.hoffman@sonosite.com |
| Telephone: | (425) 951-1297 |
| Facsimile: | (425) 951-1201 |
| Date prepared: | November 13, 2002 |
- Name of the device, including the trade or proprietary name if applicable, 2) the common or usual name, and the classification name, if known:
Common/ Usual Name
Diagnostic Ultrasound System with Accessories
Proprietary Name
SonoSite hand-carried ultrasound system (C2 Series) (subject to change)
Classification Names
| Name | FR Number | Product Code |
|---|---|---|
| Ultrasonic Pulsed Doppler Imaging System | 892.1550 | 90-IYN |
| Ultrasonic Pulsed Echo Imaging System | 892.1560 | 90-IYO |
| Diagnostic Ultrasound Transducer | 892.1570 | 90-ITX |
| Picture Archiving And Communications System | 892.2050 | 90-LLZ |
ldentification of the predicate or legally marketed device: 3)
SonoSite, Inc. believes that the System described in this Submission is substantially equivalent to a combination of the SonoSite hand-carried ultrasound system (K014116), (K010374) and the Philips Ultrasound HDI® 5000 Ultrasound System (K011224). Where applicable, this new Submission references sections of K014116 and K010374 to signify that the sections remain the same as for those predicate devices.
{1}------------------------------------------------
Device Description: 4)
The SonoSite hand-carried ultrasound system, C2 Series is a highly portable, software controlled ultrasound system used to acquire and display highresolution, real-time ultrasound data in 2D, Pulsed Wave (PW) Doppler, Continuous Wave (CW) Doppler, Color Power Doppler, Velocity Color Doppler (VCD) and Directional Color Power Doppler, or in a combination of these modes.
The System has an electrocardiography (ECG) display feature and supports a 3lead ECG cable assembly to collect data for M-mode measurements. The System provides measurement capabilities for anatomical structures and fetal biometry that provide information used for clinical diagnostic purposes. The System has a PW and CW Doppler audio output feature and cine review, image zoom, labeling, biopsy, measurements and calculations, image storage and review, printing, and recording capabilities. The system includes Digital Imaging and Communications (DICOM) to capabilities to provide the acceptance, transfer, display, storage, and digital processing of ultrasound images.
The SonoSite hand-carried ultrasound system (C2 Series) is designed to accept curved or linear transducers of the types and frequency listed in the table below. All actions affecting the performance of the transducer are activated from the main system control panel.
| Frequency Range: | 2.0 - 10.0 MHz |
|---|---|
| Transducer Types: | Linear array |
| Curved array | |
| Intracavitary array | |
| Static probes |
The SonoSite hand-carried ultrasound system (C2 Series) is designed to comply with the standards listed below.
- a. ANSI/AAMI EC 53: 1995 + Amendments, ECG Cables and Electrodes except for sections 4.4 and 4.5.9.
- b. CAN/CSA-C22.2, No. 601.1:1998, Canadian Standards Association, Medical Electrical Equipment-Part 1. General Requirements for Safety
- c. EN 60529. European Norm, Degrees of Protection Provided by Enclosures (I.P. Code)
- d. EN 60601-1:1997. European Norm, Medical Electrical Equipment-Part 1. General Requirements for Safety
- e. EN 60601-1-1:1993, European Norm, Medical Electrical Equipment Part 1. General Requirements for Safety-Section 1-1. Collateral Standard. Safety Requirements for Medical Electrical Systems
{2}------------------------------------------------
- EN 60601-1-2:2001. European Norm. Medical Electrical Equipment. General f. Requirements for Safety-Collateral Standard. Electromagnetic Compatibility. Requirements and Tests, Second Edition
- g. EN 60601-2-25:1996, European Norm, Medical Electrical Equipment-Part 2. ` Particular Requirements for Safety-Section 25. Specification for Electrocardiographs
- h. IEC 61157:1992, International Electrotechnical Commission, Requirements for the Declaration of the Acoustic Output of Medical Diagnostic Ultrasonic Equipment
- ISO 10993 Biological Evaluation of Medical Devices and Related Tests ...:
- i. JIS-T-100x Series, Japanese Standards for Medical Electrical Equipment
- Medical Ultrasound Safety, American Institute of Ultrasound in Medicine k. (AIUM), 1994
- NEMA PS3.15 2000, Digital Imaging and Communications in Medicine ﺎ . (DICOM) Part 15: Security Profile.
- m. NEMA UD2-1998. Acoustic Output Measurement Standard for Diagnostic Ultrasound Equipment
- n. NEMA UD3-1998, Standard for Real Time Display of Thermal and Mechanical Acoustic Output Indices on Diagnostic Ultrasound Equipment
- o. RTCA/DO160D:1997, Radio Technical Commission for Aeronautics, Environmental Conditions and Test Procedures for Airborne Equipment, Section 21.0 Emission of Radio Frequency Energy, Category B
- p. UL 2601-1:1999, Underwriters Laboratories, Inc., Medical Electrical Equipment-Part 1: General Requirements for Safety
- q. UL 94, Fifth Edition, Underwriters Laboratory, Inc., Tests for Flammability of Plastic Materials for Parts in Devices and Appliances
5) Intended Use:
The intended uses of the SonoSite hand-carried ultrasound system (C2 Series). as defined by FDA quidance documents, are:
| Fetal - OB/GYN | Trans-rectal |
|---|---|
| Abdominal | Trans-vaginal |
| Intra-operative | Trans-urethral |
| (Abdominal organs and vascular) | |
| Laparoscopic | Musculo-skel. (Conventional) |
| Pediatric | Musculo-skel. (Superficial) |
| Small Organ | Cardiac Adult |
| (breast, thyroid, testicles.) | |
| Neonatal Cephalic | Cardiac Pediatric |
| Adult Cephalic | Peripheral vessel |
{3}------------------------------------------------
Typical examinations performed using the SonoSite hand-carried ultrasound system (C2 Series) are:
Abdominal Imaqinq Applications:
This system transmits ultrasound energy into the abdomen of patients using 2D, M-mode, color power Doppler (CPD), directional color power Doppler (DCPD), velocity color Doppler (VCD), Tissue Harmonic Imaging (THI), pulsed wave (PW) Doppler, and continuous wave (CW) Doppler to obtain ultrasound images. The liver, kidneys, pancreas, spleen, gallbladder, bile ducts, transplanted organs, abdominal vessels, and surrounding anatomical structures can be assessed for the presence or absence of pathology transabdominally.
Cardiac Imaging Applications:
This system transmits ultrasound energy into the thorax of patients using 2D, M-mode, directional color power Doppler (DCPD), velocity color Doppler (VCD), color Doppler, Tissue Harmonic Imaging (THI), pulsed wave (PW) Doppler, and continuous wave (CW) Doppler to obtain ultrasound images. The heart, cardiac valves, great vessels, surrounding anatomical structures, overall cardiac performance, and heart size can be assessed for the presence or absence of pathology. The heart can be imaged transthoracic. The patient's electrocardiogram (ECG) may be obtained and is used for accurate timing of diastolic and systolic function.
The ECG is not used to diagnose cardiac arrhythmias and is not designed for Warning: long term cardiac rhythm monitoring.
Cephalic Imaging Applications:
This system transmits ultrasound energy into the heads of adults and neonates using 2D, M-mode, color power Doppler (CPD), directional color power Doppler (DCPD), velocity color Doppler (VCD), and pulsed wave (PW) Doppler to obtain ultrasound images. The patient's blood flow can be evaluated transcranially.
Gynecology and Infertility Imaging Applications:
This system transmits ultrasound energy in the pelvis and lower abdomen using 2D, Mmode, color power Doppler (CPD), directional color power Doppler (DCPD), velocity color Doppler (VCD), Tissue Harmonic Imaging (THI), and pulsed wave (PW) Doppler to obtain ultrasound images. The uterus, ovaries, and surrounding anatomical structures can be assessed for the presence or absence of pathology transabdominally or transvaqinally.
Interventional and Intraoperative Imaging Applications:
This system transmit ultrasound energy into the various parts of the body using 2D. color power Doppler (CPD), directional color power Doppler (DCPD), Tissue Harmonic Imaging (THI), and pulsed wave (PW) Doppler to obtain ultrasound images that provide guidance during interventional and intraoperative procedures. This system can be used to provide ultrasound guidance for biopsy and drainage procedures, vascular line placement, ova harvesting, amniocentesis and other obstetrical procedures, and provide assistance during abdominal and vascular intraoperative procedures,
{4}------------------------------------------------
Obstetrical Imaging Applications:
This system transmits ultrasound energy into the pelvis of pregnant women using 2D, M-mode, color power Doppler (CPD), directional color power (DCPD), velocity color Doppler (VCD), color Doppler, Tissue Harmonic Imaging (THI), and pulsed wave (PW) Doppler to obtain ultrasound images. The fetal anatomy, viability, estimated fetal weight, gestational age, amniotic fluid, and surrounding anatomical structures can be assessed for the presence or absence of pathology trans-abdominally or transvaginally. CPD and DCPD imaging is intended for high-risk pregnant women. High-risk pregnancy indications include, but are not limited to, multiple pregnancy, fetal hydrops, placental abnormalities, as well as maternal hypertension, diabetes, and lupus,
| Warning: | CPD or DCPD images can be used as an adjunctive method, not as a screening toolfor the detection of structural anomalies of the fetal heart and as an adjunctivemethod, not as a screening tool for the diagnosis of Intrauterine Growth Retardation(IUGR). |
|---|---|
| ---------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
Pediatric and Neonatal Imaging Applications:
This system transmits ultrasound energy into the pediatric or neonatal patients using 2D, M-mode, color power Doppler (CPD), directional color power Doppler (DCPD), velocity color Doppler (VCD), pulsed wave (PW) and continuous wave (CW) Doppler to obtain ultrasound images. The pediatric abdominal, pelvic and cardiac anatomy, pediatric hips, neonatal heads, and surrounding anatomical structures can be assessed for the presence or absence of pathology.
Prostate Imaging Applications:
This system transmits ultrasound energy into the prostate of an adult male using 2D, Mmode, color power Doppler (CPD), velocity color Doppler (VCD), and pulsed wave (PW) Doppler to obtain ultrasound images. The prostate gland can be assessed for the presence or absence of pathology transrectally.
Superficial Imaging Applications:
This system transmits ultrasound energy into various parts of the body using 2D. M-mode, color power Doppler (CPD), velocity color Doppler (VCD), and pulsed wave (PW) Doppler to obtain ultrasound images. The breast, thyroid, testicle, lymph nodes, hernias, musculoskeletal structures, soft tissue structures, and surrounding anatomical structures can be assessed for the presence or absence of pathology.
Vascular Imaging Applications:
This system transmits ultrasound energy into the various parts of the body using 2D, Mmode, color power Doppler (CPD), velocity color Doppler (VCD), Tissue Harmonic Imaging (THI), and pulsed wave (PW) Doppler to obtain ultrasound images. The carotid arteries, deep veins in the arms and legs, superficial veins in the arms and legs, great vessels in the abdomen, and various small vessels feeding organs can be assessed for the presence or absence of pathology.
{5}------------------------------------------------
Technological Characteristics: 6)
This device operates identically to the predicate devices in that piezoelectric material in the transducer is used as an ultrasound source to transmit sound waves into the body. Sound waves are reflected back to the transducer and converted to electrical signals that are processed and displayed as 2D or Mmode images. Doppler shift caused by blood flow is displayed as Color Flow, or as spectrum analysis. The modes of this device (2D, PW Doppler, CW Doppler, velocity color Doppler, Color Power Doppler, and directional color power Doppler, and duplex imaging) are the same as a combination of the predicate devices identified in item 3. Transducer patient contact materials are biocompatible.
This device conforms to the Standard for Real-Time Display of Thermal and Mechanical Acoustic Output Indices on Diagnostic Ultrasound Equipment (AIUM/NEMA. 1998) for an on-screen display feature that provides information on potential thermal and cavitation bioeffect mechanisms. A user education program provides additional information so users may moderate the system's acoustic output in accordance with the ALARA (as low as reasonably achievable) principle.
The device's acoustic output limits are:
All applications:
| ISPTA (d) | 720 mW/cm² (Maximum) |
|---|---|
| TIS/TIB/TIC | 0.1 - 4.0 (Range) |
| Mechanical Index (MI) | 1.9 (Maximum) |
| ISPPA (d) | 0 - 700 W/cm² (Range) |
The limits are the same as predicate Track 3 devices.
{6}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/6/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it, often associated with medicine and healthcare. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the caduceus symbol.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC 13 2002
SonoSite, Inc. % Mr. Mark Job 510(k) Program Manager TÜV Product Service 1775 Old Highway 8 NEW BRIGHTON MN 55112-1891
Re: K023957
Trade Name: SonoSite Hand-carried Ultrasound System (C2 Series) Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulation Number: 21 CFR 892.1570 Regulation Name: Diagnostic ultrasonic transducer Regulatory Class: II Product Code: 90 IYN, IYO. and ITX Dated: November 26, 2002 Received: November 27, 2002
Dear Mr. Job
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the SonoSite Hand-carried Ultrasound System, as described in your premarket notification:
Transducer Model Number
C11/7-4 7.0-4.0 MHz Curved Array C11e/10-5 10.0-5.0 MHz Curved Array
{7}------------------------------------------------
C15/4-2 4.0-2.0 MHz Curved Array C60/5-2 5.0-2.0 MHz Curved Array HST/10-5 10.0-5.0 MHz Linear Array ICT/7-4 7.0-4.0 MHz Intracavitary C8/8-5 8.0-5.0 MHz Prostate ICTe/10-5 10.0 -5.0 MHz Intracavitary L25/10-5 10.0-5.0 MHz Linear Array L38/10-5 10.0-5.0 MHz Intracavitary . L52/10-5 and L52S/10-5 10.0-5.0 MHz Linear Array 2.0 MHz Dual Element Circular Array
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G, (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.
The special report should reference the manufacturer's 510(k) number. It should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:
Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
{8}------------------------------------------------
Page 3 - Mr. Job
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801, please contact the Office of Compliance at (301) 594-4591. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket " notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".
If you have any questions regarding the content of this letter, please contact Rodrigo C. Perez at (301) 594-1212.
Lor
Sincerely yours,
Third St. Lynn
Nancy C. Brogdon Director, Division of Reproductive. Abdominal and Radiological Devices Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure(s)
{9}------------------------------------------------
K04 395 7
D02345B - C2 510(k) submission 13-Nov-2002, Pg. 29 of 587
| System: | SonoSite hand-carried ultrasound system, version C2 | |||||||
|---|---|---|---|---|---|---|---|---|
| Transducer: | N/A | |||||||
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:: | |||||||
| Clinical Application | Mode of Operation | |||||||
| General(Track I only) | Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined(Spec.) | Other(Spec.) |
| Ophthalmic | Ophthalmic | |||||||
| Fetal | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||
| AbdominalIntra-operative(Abdominal organs andvascular) | P | P | P | P | N | B+M; B+PWD;B+CWD;B+CD | Note 1 | |
| Fetal Imaging | Intra-operative (Neuro.)Laparoscopic | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | |
| B+M; B+PWD;B+CWD;B+CD | ||||||||
| & Other | PediatricSmall Organ (breast,thyroid, testicles.) | P | P | P | P | N | B+M; B+PWD;B+CD | Note 1 |
| B+M; B+PWD;B+CWD; | ||||||||
| Neonatal Cephalic | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||
| Adult Cephalic | N | N | N | N | B+M;B+PWD;B+CD | Note 1 | ||
| Trans-rectal | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||
| Trans-vaginalTrans-urethral | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||
| Trans-esoph. (non-Card.)Musculo-skel. (Convent.) | P | P | P | B+M; B+PWD | Note 1 | |||
| Musculo-skel. (Superfic.)Intra-luminalOther (spec.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||
| Cardiac Adult | P | P | P | P | N | B+M; B+PWD;B+CWD;B+CD | Note 1 | |
| Cardiac | Cardiac PediatricTrans-esophageal (card.)Other (spec.) | P | P | P | P | N | B+M; B+PWD;B+CWD;B+CD | Note 1 |
| PeripheralVessel | Peripheral vesselOther (spec.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 |
Table 1- Diagnostic Ultrasound Indications for Use Form - C2 System
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
Note 1: Other includes Color Power Doppler, combined B and Color Power Doppler, combined B and Directional Color Power Doppler, 3-D Imaging, Tissue Harmonic Imaging for guidance of biopsy previously cleared through 510(K) K014116. Included with this 510k inveging to assist in the placement of needles and catheters in vascular or other anatomical structures.
Color Doppler includes Velocity Color Doppler.
Prescription Use (Per 21 CFR 801.109)
David G. Watson
(Division Sign-Off)
Indications for Use
(Division Sign-Off)
Division of Reproductive, Abdominal,
and Radiological Devices
510(k) Number K023957
S
Section 4.3
{10}------------------------------------------------
Table 2 - Diagnostic Ultrasound Indications for Use For
| System: | SonoSite hand-carried ultrasound system, version C2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Transducer: | C11/7-4 7.0 - 4.0 MHz Curved Array | ||||||||
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | ||||||||
| Clinical Application | Mode of Operation | ||||||||
| General(Track I only) | Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined(Spec.) | Other(Spec.) | |
| Ophthalmic | Ophthalmic | ||||||||
| Fetal | |||||||||
| AbdominalIntra-operative (Abdominalorgans and vascular)Intra-operative (Neuro.)Laparoscopic | P | P | P | P | N | B+M; B+PWD;B+CWD; B+CD | Note 1 | ||
| Fetal Imaging& Other | PediatricSmall Organ (breast,thyroid, testicles.) | P | P | P | P | N | B+M; B+PWD;B+CWD; B+CD | Note 1 | |
| Neonatal Cephalic | P | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||
| Adult CephalicTrans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skel. (Convent.)Musculo-skel. (Superfic.)Intra-luminalOther (spec.)Cardiac Adult | |||||||||
| Cardiac | Cardiac PediatricTrans-esophageal (card.)Other (spec.) | P | P | P | P | N | B+M; B+PWD;B+CWD; B+CD | Note 1 | |
| PeripheralVessel | Peripheral vesselOther (spec.) | P | P | P | P | N | B+M; B+PWD;B+CD | Note 1 |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
Note 1: Other includes Color Power Doppler, combined B and Color Power Doppler, combined B and Directional Color Power Doppler, 3-D rroso in other mades over refror a pridance of biopsy previously cleared through 510(k) K014116. Included with this 510k are imaging to assist in the placement of needles and catheters in vascular or other anatomical structures.
Color Doppler includes Velocity Color Doppler.
David A. Segegm
(Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number
{11}------------------------------------------------
D02345B - C2 510(k) submission 13-Nov-2002, Pg. 31 of 587
| Table 3 - Diagnostic Ultrasound Indications for Use Form - C11e/10-5 Transducer |
|---|
| --------------------------------------------------------------------------------- |
| System: | SonoSite hand-carried ultrasound system, version C2 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Transducer: | C11e/10-5 10.0 - 5.0 MHz Curved Array | ||||||||||
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | ||||||||||
| Clinical Application | Mode of Operation | ||||||||||
| General(Track I only) | Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined(Spec.) | Other(Spec.) | |||
| Ophthalmic | Ophthalmic | ||||||||||
| Fetal | |||||||||||
| Abdominal | N | N | N | N | N | B+M; B+PWD;B+CWD; B+CD | Note 1 | ||||
| Intra-operative (Abdominalorgans and vascular) | |||||||||||
| Intra-operative (Neuro.) | |||||||||||
| Fetal Imaging | Laparoscopic | ||||||||||
| & Other | PediatricSmall Organ (breast,thyroid, testicles.) | N | N | N | N | N | B+M; B+PWD;B+CWD; B+CD | Note 1 | |||
| Neonatal Cephalic | N | N | N | N | N | B+M; B+PWD;B+CD | Note 1 | ||||
| Adult Cephalic | |||||||||||
| Trans-rectal | |||||||||||
| Trans-vaginal | |||||||||||
| Trans-urethral | |||||||||||
| Trans-esoph. (non-Card.) | |||||||||||
| Musculo-skel. (Convent.) | |||||||||||
| Musculo-skel. (Superfic.) | |||||||||||
| Intra-luminal | |||||||||||
| Other (spec.) | |||||||||||
| Cardiac Adult | |||||||||||
| Cardiac | Cardiac Pediatric | N | N | N | N | N | B+M; B+PWD;B+CWD; B+CD | Note 1 | |||
| Trans-esophageal (card.) | |||||||||||
| Other (spec.) | |||||||||||
| PeripheralVessel | Peripheral vessel | N | N | N | N | N | B+M; B+PWD;B+CD | Note 1 | |||
| Other (spec.) |
N= new Indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
Note 1: Other includes Color Power Dopler, combined B and Coior Power Doppier, combined B and Diet Power Doppler, Co Note 1: Other Includes Color Power Depler over Depple, Combition of any office of a filter his only of the Michiel Octor of Pine Housed With this 16. Included with this new imaging, Tissue Tramonic maging, and maging for gridation of breasular or other anatomical structures.
Color Doppler includes Velocity Color Doppler.
Ehrind G. Slayman
(Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number _
{12}------------------------------------------------
e 4 - Diagnostic Ultrasound Indications for Use Form - C15/4-2 Tr
| System: | SonoSite hand-carried ultrasound system, version C2 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transducer: | C15/4-2 4.0 - 2.0 MHz Curved Array | |||||||||||
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | |||||||||||
| Clinical Application | Mode of Operation | |||||||||||
| General(Track I only) | Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined.(Spec.) | Other(Spec.) | ||||
| Ophthalmic | Ophthalmic | |||||||||||
| Fetal | P | P | P | B+M; B+PWD | Note 1 | |||||||
| Abdominal | P | P | P | P | N | B+M; B+PWD;B+CWD; B+CD | Note 1 | |||||
| Intra-operative (Abdominalorgans and vascular) | P | P | P | B+M; B+PWD | Note 1 | |||||||
| Fetal Imaging& Other | Intra-operative (Neuro.)LaparoscopicPediatric | P | P | P | B+M; B+PWD | Note 1 | ||||||
| Small Organ (breast,thyroid, testicles.) | P | P | P | B+M; B+PWD | Note 1 | |||||||
| Neonatal Cephalic | P | P | P | B+M; B+PWD | Note 1 | |||||||
| Adult Cephalic | N | N | N | N | B+M; B+PWD;B+CD | Note 1 | ||||||
| Trans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skel. (Convent.)Musculo-skel. (Superfic.)Intra-luminalOther (spec.) | ||||||||||||
| Musculo-skel. (Convent.) | P | P | P | B+M; B+PWD | Note 1 | |||||||
| Cardiac | Cardiac Adult | P | P | P | P | N | B+M; B+PWD;B+CWD; B+CD | Note 1 | ||||
| Cardiac Pediatric | P | P | P | P | N | B+M; B+PWD;B+CWD; B+CD | Note 1 | |||||
| Trans-esophageal (card.)Other (spec.) | Note 1 | |||||||||||
| Peripheral vessel | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||||||
| PeripheralVessel | Other (spec.) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
Note 1: Other includes Color Power Dopler, combined B and Color Power Doppler, combined B and Directional Color Power Doppler, 3-D Imaging, Tissue Harnonic Imaging for guidance of biopsy previously cleared through 510(k) K014116. Included with this 510k are imaging to assist in the placement of needies and catheters in vascular or other analorrical structures. Color Doppler includes Velocity Color Doppler.
David G. Legnon
(Division Sign-Off) Division of Reproductive, Abdo and Radiological Devices 510(k) Number .
{13}------------------------------------------------
| System: | SonoSite hand-carried ultrasound system, version C2 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Transducer: | C60/5-2 5.0-2.0 MHz Curved Array | |||||||||
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as | |||||||||
| follows: | ||||||||||
| Clinical Application | Mode of Operation | |||||||||
| General(Track I only) | Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined(Spec.) | Other(Spec.) | ||
| Ophthalmic | Ophthalmic | |||||||||
| Fetal | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||||
| Abdominal | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||||
| Intra-operative (Abdominalorgans and vascular) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||||
| Intra-operative (Neuro.)Laparoscopic | ||||||||||
| Fetal Imaging | ||||||||||
| Pediatric | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||||
| & Other | Small Organ (breast,thyroid, testicles.) | |||||||||
| Neonatal Cephalic | ||||||||||
| Adult Cephalic | ||||||||||
| Trans-rectal | ||||||||||
| Trans-vaginal | ||||||||||
| Trans-urethral | ||||||||||
| Trans-esoph. (non-Card.) | ||||||||||
| Musculo-skel. (Convent.) | ||||||||||
| Musculo-skel. (Superfic.) | ||||||||||
| Intra-luminal | ||||||||||
| Other (spec.) | ||||||||||
| Cardiac Adult | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||||
| Cardiac | Cardiac PediatricTrans-esophageal (card.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | |||
| Other (spec.) | ||||||||||
| Peripheral | Peripheral vessel | |||||||||
| Vessel | Other (spec.) | |||||||||
Table 5 - Diagnostic Ultrasound Indications for Use Form - C60/5-2 Transducer
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
Note 1: Other includes Color Power Doppler, combined B and Color Power Doppler, combined B and Directional Color Power Doppler, 3-D Imaging, Tissue Harmonic Imaging for guidance of biopsy previously cleared through 510(k) K014116. Included with this 510k are imaging to assist in the placement of needles and catheters in vascular or other anatomical structures.
Color Doppler includes Velocity Color Doppler.
Daniel A. Logemann
(Division Sign-Off) Division of Reproductive, Ab and Radiological Devices 510(k) Number .
{14}------------------------------------------------
K03 3.4.5.7
| Table 6 - Diagnostic Ultrasound Indications for Use Form - HST/10-5 Transducer | |||
|---|---|---|---|
| System: | SonoSite hand-carried ultrasound system, version C2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Transducer: | HST/10-5 10.0-5.0 MHz Linear Array Transducer | ||||||||
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | ||||||||
| Clinical Application | Mode of Operation | ||||||||
| General(Track I only) | Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined(Spec.) | Other(Spec.) | |
| Ophthalmic | Ophthalmic | ||||||||
| Fetal | |||||||||
| Abdominal | |||||||||
| Intra-operative (Abdominalorgans and vascular) | E | E | E | N | B+M; B+PWD;B+CD | Note 1 | |||
| Intra-operative (Neuro.) | |||||||||
| Fetal Imaging | Laparoscopic | ||||||||
| B+M; B+PWD;B+CD | |||||||||
| & Other | Pediatric | E | E | E | N | B+M; B+PWD;B+CD | Note 1 | ||
| Small Organ (breast,thyroid, testicles.) | E | E | E | N | B+M; B+PWD;B+CD | Note 1 | |||
| Neonatal Cephalic | |||||||||
| Adult Cephalic | |||||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph. (non-Card.) | |||||||||
| Musculo-skel. (Convent.) | E | E | E | B+M; B+PWD;B+CD | Note 1 | ||||
| Musculo-skel. (Superfic.) | E | E | E | N | B+M; B+PWD;B+CD | Note 1 | |||
| Intra-luminal | |||||||||
| Other (spec.) | |||||||||
| Cardiac Adult | |||||||||
| Cardiac | Cardiac Pediatric | ||||||||
| Trans-esophageal (card.)Other (spec.) | |||||||||
| PeripheralVessel | Peripheral vesselOther (spec.) | E | E | E | N | B+M; B+PWD;B+CD | Note 1 |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
Note 1: Other includes Color Power Dopler, combined B and Color Power Doppler, combined B and Directional Color Power Dopler, 3-D Imaging, Tissue Harnonic Imaging for guidance of biopsy previously cleared through 510(K) K014116. Included with this 510k are imaging to assist in the placement of needles and catheters in vascular or other anatomical structures. Color Doppler includes Velocity Color Doppler.
David C. Bohrman
(Division Sign-Off) Division of Reproductive, Abdom ം i Radiological Devices ്(k) Number _________________________________________________________________________________________________________________________________________________________________
{15}------------------------------------------------
Table 7 - Diagnostic Ultrasound Indications for Use Form - ICT/7-4 Transdu
| Clinical Application | Mode of Operation | Other(Spec.) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| General(Track I only) | Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined(Spec.) | ||
| Ophthalmic | Ophthalmic | ||||||||
| Fetal | P | P | P | N | B+M; B+PWD;B+CD | Note 1. | |||
| Abdominal | |||||||||
| Intra-operative (Abdominalorgans and vascular) | |||||||||
| Intra-operative (Neuro.) | |||||||||
| Fetal Imaging& Other | Laparoscopic | ||||||||
| Pediatric | |||||||||
| Small Organ (breast,thyroid, testicles.) | |||||||||
| Neonatal Cephalic | |||||||||
| Adult Cephalic | |||||||||
| Trans-rectal | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | |||
| Trans-vaginal | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | |||
| Trans-urethral | |||||||||
| Trans-esoph. (non-Card.) | |||||||||
| Musculo-skel. (Convent.) | |||||||||
| Musculo-skel. (Superfic.) | |||||||||
| Intra-luminal | |||||||||
| Other (spec.) | |||||||||
| Cardiac Adult | |||||||||
| Cardiac | Cardiac Pediatric | ||||||||
| Trans-esophageal (card.) | |||||||||
| Other (spec.) | |||||||||
| PeripheralVessel | Peripheral vessel | ||||||||
| Other (spec.) |
N= new indication; P=previously cleared by FDA; E= added under Appendix E
Additional Comments:
Note 1: Other includes Color Power Dopler, combined B and Color Power Doppler, combined B and Directional Color Power Doppler, 3-D Imaging, Tissue Harmonic Imaging for guidance of biopsy previously cleared through 510(K) K014116. Included with this 510k are imaging to assist in the placement of needles and catheters in vascular or other anatomical structures. Color Doppler includes Velocity Color Doppler.
David C. Leyman
(Division Sign-Off) Division of Reproductive, Abdomin and Radiological Devices 510(k) Number _
{16}------------------------------------------------
K04 3757
| System: | SonoSite hand-carried ultrasound system, version C2 | |||||||
|---|---|---|---|---|---|---|---|---|
| Transducer: | C8/8-5 8.0- 5.0 MHz Prostate Transducer | |||||||
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body asfollows: | |||||||
| Clinical Application | ||||||||
| Mode of Operation | ||||||||
| General(Track I only) | Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined(Spec.) | Other(Spec.) |
| Ophthalmic | Ophthalmic | |||||||
| Fetal | N | N | N | N | B+M; B+PWD;B+CD | Note 1 | ||
| Abdominal | ||||||||
| Intra-operative (Abdominalorgans and vascular) | ||||||||
| Intra-operative (Neuro.) | ||||||||
| Fetal Imaging& Other | LaparoscopicPediatric | |||||||
| Small Organ (breast,thyroid, testicles.) | ||||||||
| Neonatal CephalicAdult Cephalic | ||||||||
| Trans-rectal | N | N | N | N | B+M; B+PWD;B+CD | Note 1 | ||
| Trans-vaginal | N | N | N | N | B+M; B+PWD;B+CD | Note 1 | ||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.) | ||||||||
| Musculo-skel. (Convent.)Musculo-skel. (Superfic.) | ||||||||
| Intra-luminalOther (spec.) | ||||||||
| Cardiac Adult | ||||||||
| Cardiac | Cardiac PediatricTrans-esophageal (card.)Other (spec.) | |||||||
| PeripheralVessel | Peripheral vesselOther (spec.) |
Diagnostic Ultrasound Indications for Use Form - C8/8-5
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
Note 1: Other includes Color Power Dopler, combined B and Color Power Doppler, combined B and Directional Color Power Doppler, 3-D Imaging, Tissue Harmonic Imaging for guidance of biopsy previously cleared through 510(k) K014116. Included with this 510k are imaging to assist in the placement of needles and catheters in vascular or other anatomical structures.
Color Doppler includes Velocity Color Doppler.
Daniel G. Legrain
(Division Sign-Off) Division of Reproductive, and Radiological Devices 510(k) Number
{17}------------------------------------------------
KLB 3951
| Table 9 - Diagnostic Ultrasound Indications for Use Form - ICTe/10-5 Transduce | |||
|---|---|---|---|
| Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|
| System: | SonoSite hand-carried ultrasound system, version C2 | |||||||
| Transducer: | ICTe/10-5 10.0- 5.0 MHz Intracavitary Transducer | |||||||
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body asfollows: | |||||||
| Clinical Application | ||||||||
| Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined(Spec.) | Other(Spec.) | |
| General(Track I only) | ||||||||
| Ophthalmic | Ophthalmic | |||||||
| B+M; B+PWD;B+CD | Note 1 | |||||||
| Fetal | N | N | N | N | N | B+M; B+PWD;B+CD | Note 1 | |
| Abdominal | ||||||||
| Intra-operative (Abdominalorgans and vascular) | ||||||||
| Intra-operative (Neuro.) | ||||||||
| Fetal Imaging& Other | Laparoscopic | |||||||
| PediatricSmall Organ (breast,thyroid, testicles.) | ||||||||
| Neonatal Cephalic | ||||||||
| Adult Cephalic | ||||||||
| Trans-rectal | N | N | N | N | N | B+M; B+PWD;B+CD | Note 1 | |
| Trans-vaginal | N | N | N | N | N | B+M; B+PWD;B+CD | Note 1 | |
| Trans-urethralTrans-esoph. (non-Card.) | ||||||||
| Musculo-skel. (Convent.) | ||||||||
| Musculo-skel. (Superfic.) | ||||||||
| Intra-luminal | ||||||||
| Other (spec.) | ||||||||
| Cardiac | Cardiac Adult | |||||||
| Cardiac Pediatric | ||||||||
| Trans-esophageal (card.) | ||||||||
| Other (spec.) | ||||||||
| PeripheralVessel | Peripheral vessel | |||||||
| Other (spec.) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
Note 1: Other includes Color Power Doppler, combined B and Color Power Doppler, combined B and Directional Color Power Doppler, 3-D Imaging, Tissue Harmonic Imaging for guidance of biopsy previously cleared through 510(k) K014116. Included with this 510k ine imaging to assist in the placement of needles and catheters in vascular or other anatomical structures. Color Doppler includes Velocity Color Doppler.
Color Doppler includes Velocity Color Doppler
Quist G. Legman
(Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number
{18}------------------------------------------------
| Clinical Application | Mode of Operation | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| System: | SonoSite hand-carried ultrasound system, version C2 | |||||||||
| Transducer: | L25/10-5 10.0-5.0 MHz Linear Array | |||||||||
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | |||||||||
| General(Track I only) | Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined(Spec.) | Other(Spec.) | ||
| Ophthalmic | Ophthalmic | |||||||||
| Fetal | P | P | P | B+M; B+PWD | Note 1 | |||||
| Abdominal | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||||
| Intra-operative (Abdominalorgans and vascular) | P | P | P | B+M; B+PWD | Note 1 | |||||
| Fetal Imaging | Intra-operative (Neuro.)Laparoscopic | P | P | P | B+M; B+PWD | Note 1 | ||||
| & Other | PediatricSmall Organ (breast,thyroid, testicles.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | |||
| Neonatal CephalicAdult Cephalic | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||||
| Trans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skel. (Convent.) | P | P | P | B+M; B+PWD | Note 1 | |||||
| Musculo-skel. (Superfic.)Intra-luminalOther (spec.)Cardiac Adult | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||||
| Cardiac | Cardiac PediatricTrans-esophageal (card.)Other (spec.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | |||
| Peripheral | Peripheral vesselOther (spec.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 |
Table 10 - Diagnostic Ultrasound Indications for Use Form – L25/10-5 Transduc
N= new indication; P = previously cleared by FDA; E= added under Appendix E
Additional Comments:
Note 1: Other includes Color Power Dopler, combined B and Color Power Doppler, combined B and Directional Color Power Doppler, 3-D rround in Stree Harmonic Inc. Depirer just be of biopsy previously cleared through 510(k) K014116. Included with this 510k are imaging to assist in the placement of needles and catheters in vascular or other anatomical structures. Color Doppler includes Velocity Color Doppler.
Color Doppler includes velocity Color Doppler
David K. Sezman
(Division Sign-Off) Division of Reproductive, Abdomina and Radiological Devices 510(k) Number
{19}------------------------------------------------
| SonoSite hand-carried ultrasound system, version C2System: | ||||||||
|---|---|---|---|---|---|---|---|---|
| Transducer: | L38/10-5 10.0- 5.0 MHz Intracavitary Transducer | |||||||
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | |||||||
| Clinical Application | Mode of Operation | |||||||
| General(Track I only) | Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined(Spec.) | Other(Spec.) |
| Ophthalmic | Ophthalmic | |||||||
| Fetal | P | P | P | B+M; B+PWD | Note 1 | |||
| AbdominalIntra-operative (Abdominalorgans and vascular) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||
| Intra-operative (Neuro.) | ||||||||
| Fetal Imaging | Laparoscopic | P | P | P | B+M; B+PWD | Note 1 | ||
| & Other | PediatricSmall Organ (breast,thyroid, testicles.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | |
| Neonatal Cephalic | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||
| Adult Cephalic | ||||||||
| Trans-rectal | ||||||||
| Trans-vaginal | ||||||||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.)Musculo-skel. (Convent.) | P | P | P | B+M; B+PWD | Note 1 | |||
| Musculo-skel. (Superfic.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||
| Intra-luminal | ||||||||
| Other (spec.)Cardiac Adult | ||||||||
| Cardiac | Cardiac PediatricTrans-esophageal (card.)Other (spec.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | |
| PeripheralVessel | Peripheral vesselOther (spec.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 |
Table 11 - Diagnostic Ultrasound Indications for Use Form - L38/10-5 Transo
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
Note 1: Other includes Color Power Dopler, combined B and Color Power Doppler, combined B and Directional Color Power Doppler, 3-D Imaging, Tissue Harmonic Imaging for guidance of biopsy previously cleared through 510(k) K014116. Included with this 510k are imaging to assist in the placement of needles and catheters in vascular or other anatomical structures. Color Doppler includes Velocity Color Doppler.
David A. Lyman
(Division Sign-Off) Division of Reproductive, Abdominal. and Radiological Devices 5 10(k) Number _
{20}------------------------------------------------
KD23957
Table 12 - Diagnostic Ultrasound Indications for Use Form -- L52/10-5 & L52-S/10-5 Transducers
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General(Track I only) | Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined(Spec.) | Other(Spec.) | |
| Ophthalmic | Ophthalmic | ||||||||
| Fetal | P | P | P | B+M; B+PWD | Note 1 | ||||
| Abdominal | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | |||
| Intra-operative (Abdominalorgans and vascular) | P | P | P | B+M; B+PWD | Note 1 | ||||
| Intra-operative (Neuro.)Laparoscopic | P | P | P | B+M; B+PWD | Note 1 | ||||
| Fetal Imaging& Other | Pediatric | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||
| Small Organ (breast,thyroid, testicles.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | |||
| Neonatal CephalicAdult Cephalic | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | |||
| Trans-rectalTrans-vaginalTrans-urethralTrans-esoph. (non-Card.)Musculo-skel. (Convent.) | P | P | P | B+M; B+PWD | Note 1 | ||||
| Musculo-skel. (Superfic.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | |||
| Intra-luminalOther (spec.)Cardiac Adult | |||||||||
| Cardiac | Cardiac PediatricTrans-esophageal (card.)Other (spec.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 | ||
| PeripheralVessel | Peripheral vesselOther (spec.) | P | P | P | N | B+M; B+PWD;B+CD | Note 1 |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
Note 1: Other includes Color Power Doppler, combined B and Color Power Doppler, combined B and Directional Color Power Doppler, 3-D Imaging, Tissue Harmonic Imaging for guidance of biopsy previously cleared through 510(K) K014116. Included with this 510k are imaging to assist in the placement of needles and catheters in vascular or other anatomical structures.
Color Doppler includes Velocity Color Doppler.
David A. Legum
(Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number __
{21}------------------------------------------------
K 023957
.
| System: | SonoSite hand-carried ultrasound system, version C2 | |||||||
|---|---|---|---|---|---|---|---|---|
| Transducer: | Doppler Pencil Transducer 2.0 MHz Dual Element Circular Array | |||||||
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body asfollows: | |||||||
| Clinical Application | Mode of Operation | |||||||
| General(Track I only) | Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined(Spec.) | Other(Spec.) |
| Ophthalmic | Ophthalmic | |||||||
| Fetal Imaging& Other | Fetal | |||||||
| Abdominal | ||||||||
| Intra-operative (Abdominalorgans and vascular) | ||||||||
| Intra-operative (Neuro.) | ||||||||
| Laparoscopic | ||||||||
| Pediatric | ||||||||
| Small Organ (breast,thyroid, testicles.) | ||||||||
| Neonatal Cephalic | ||||||||
| Adult Cephalic | ||||||||
| Trans-rectal | ||||||||
| Trans-vaginal | ||||||||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.) | ||||||||
| Musculo-skel. (Convent.) | ||||||||
| Musculo-skel. (Superfic.) | ||||||||
| Intra-luminal | ||||||||
| Other (spec.) | ||||||||
| Cardiac | Cardiac Adult | N | ||||||
| Cardiac Pediatric | N | |||||||
| Trans-esophageal (card.) | ||||||||
| Other (spec.) | ||||||||
| PeripheralVessel | Peripheral vessel | |||||||
| Other (spec.) |
Table 13 - Diagnostic Ultrasound Indications for Use Form - 2 MHz Doppler Pencil
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Daniel A. Lehman
(Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number __
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.